Download PDF
Planta Med 2010; 76(3): 265-272
DOI: 10.1055/s-0029-1186137
Pharmacology
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Anti-herpetic Properties of Hydroalcoholic Extracts and Pressed Juice from Echinacea pallida

Sven Schneider1 , Jürgen Reichling2 , Florian C. Stintzing3 , Silke Messerschmidt3 , Ulrich Meyer3 , Paul Schnitzler1
  • 1Department of Virology, Hygiene Institute, University of Heidelberg, Heidelberg, Germany
  • 2Department of Biology, Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany
  • 3WALA Heilmittel GmbH, Bad Boll/Eckwälden, Germany
Further Information

Publication History

received February 18, 2009 revised July 20, 2009

accepted August 16, 2009

Publication Date:
29 September 2009 (online)

    Permissions and Reprints

Abstract

Hydroalcoholic extracts and pressed juice from Echinacea pallida were phytochemically characterised by HPLC‐MS analyses. Ferulic and caffeic acid derivatives were identified as major constituents. All tested extracts and pressed juice from Echinacea pallida exhibited a low cytotoxic activity on monkey kidney cells in vitro. The inhibitory activity of Echinacea against herpes simplex virus types 1 and 2 (HSV-1, HSV-2) was analysed with plaque reduction assays. All hydroalcoholic extracts exhibited high levels of antiviral activity against both types of herpesvirus in a dose-dependent manner. Plaque formation was significantly reduced by more than 99 % or completely absent. Pressed juice from E. pallida revealed the highest antiviral activity against HSV-1 and HSV-2 when compared to hydroalcoholic Echinacea extracts and even highly diluted Echinacea pressed juice still inhibited viral infectivity. Hydroalcoholic extracts were quite active against herpetic infection when HSV-1 or HSV-2 were pretreated with the extracts. In contrast, Echinacea pressed juice revealed antiviral activity during all phases of the viral replication cycle. Additionally, Echinacea pressed juice demonstrated protection of cells against viral infection. In conclusion, hydroalcoholic E. pallida extracts interfere with free herpesvirus but pressed juice is able to interact with herpesvirus inside and outside the cell as well as to protect cells against viral infection, probably by interfering with virus attachment. Hydroalcoholic extracts and pressed juice from E. pallida demonstrated high selectivity indices, a necessary prerequisite for a potential topical treatment of herpetic infections. Different types of Echinacea preparations, such as commercial tinctures, tablets, and teas, are expected to offer different antiviral profiles.

Key words

antiviral - herpes simplex virus - Echinacea pallida - Asteraceae - hydroalcoholic extract - Echinacea pressed juice

References

  • 1 Chen Y, Scieux V, Garrait V, Socié G, Rocha V, Molina J M, Thouvenot D, Morfin F, Hocqueloux I, Garderei L, Esperou H, Selimi F, Dervergie A, Lelen G, Aymard M, Morinet F, Gluckman E, Ribaud P. Resistent herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.  Clin Infect Dis. 2000;  31 927-935
    CrossrefPubMedGoogle Scholar
  • 2 De Clercq E. Antiviral drugs in current clinical use.  J Clin Virol. 2004;  30 115-133
    CrossrefPubMedGoogle Scholar
  • 3 Bacon T H, Levin M J, Leary J J, Sarisky R T, Sutton D. Herpes simplex virus resistance to acyclovir and pencyclovir after two decades of antiviral therapy.  Clin Microbiol Rev. 2003;  16 114-128
    CrossrefPubMedGoogle Scholar
  • 4 Koytchev R, Alken R G, Dundarov S. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.  Phytomedicine. 1999;  6 225-230
    CrossrefPubMedGoogle Scholar
  • 5 Carson C F, Ashton L, Dry L, Smith D W, Riley T V. Melaleuca alternifolia (tea tree) oil gel (6 %) for the treatment of recurrent herpes labialis.  Antimicrob Agents Chemother. 2001;  48 450-451
    CrossrefPubMedGoogle Scholar
  • 6 Jassim S A, Naji M A. Novel antiviral agents: a medicinal plant perspective.  J Appl Microbiol. 2003;  95 412-427
    CrossrefPubMedGoogle Scholar
  • 7 Barrett B. Medicinal properties of Echinacea: a critical review.  Phytomedicine. 2003;  10 66-86
    CrossrefPubMedGoogle Scholar
  • 8 Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the common cold.  Planta Med. 2008;  74 633-637
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Goel V, Lovlin R, Chang C, Slama J V, Barton R, Gahler R, Bauer R, Goonewardene L, Basu T K. A proprietary extract from the Echinacea plant (Echinacea purpurea) enhances systemic immune responses during a common cold.  Phytother Res. 2005;  19 689-694
    CrossrefPubMedGoogle Scholar
  • 10 Linde K, Barrett B, Woelkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold.  Cochrane Database Syst Rev. 2006;  (1) CD000530
    PubMedGoogle Scholar
  • 11 Woelkart K, Bauer R. The role of alkamides as an active principle of Echinacea.  Planta Med. 2007;  73 615-623
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Zwickey H, Brush J, Iacullo C M, Connelly E, Gregory W L, Soumyanath A, Buresh R. The effect of Echinacea purpurea, Astralagus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: a pilot study.  Phytother Res. 2007;  21 1109-1112
    CrossrefPubMedGoogle Scholar
  • 13 Wacker A, Hilbig A. Virus inhibition by Echinacea purpurea.  Planta Med. 1978;  33 89-102
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Thompson K D. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus.  Antiviral Res. 1998;  39 55-61
    CrossrefPubMedGoogle Scholar
  • 15 Vimalanathan S, Kang L, Amiguet V T, Livesey J, Arnason J T, Hudson J. Echinacea purpurea aerial parts contain multiple antiviral compounds.  Pharm Biol. 2005;  43 740-745
    CrossrefPubMedGoogle Scholar
  • 16 Hudson J, Vimalananthan S, Kang I, Amiguet V T, Livesey J, Amason J T. Characterization of antiviral activities in Echinacea root preparations.  Pharm Biol. 2005;  43 790-796
    CrossrefPubMedGoogle Scholar
  • 17 Schnitzler P, Koch C, Reichling J. Susceptibility of drug-resistant clinical HSV-1 strains to essential oils of ginger, thyme, hyssop and sandalwood.  Antimicrob Agents Chemother. 2007;  51 1859-1862
    CrossrefPubMedGoogle Scholar
  • 18 Reichling J, Koch C, Stahl-Biskup E, Sojka C, Schnitzler P. Virucidal activity of a β-triketone-rich essential oil of Leptospermum scoparium (manuka oil) against HSV-1 and HSV-2 in cell culture.  Planta Med. 2005;  71 1123-1127
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Bauer R, Remiger P, Wagner H. Echinacea – Vergleichende DC- und HPLC-Analyse der Herba-Drogen von Echinacea purpurea, E. pallida und E. angustifolia (3. Mitt.).  Dtsch Apotheker Ztg. 1988;  128 174-180
    PubMedGoogle Scholar
  • 20 Woelkart K, Dittrich P, Beubler E, Pini F, Schoop R, Suter A, Bauer R. Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans.  Planta Med. 2008;  74 651-656
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Woelkart K, Marth E, Suter A, Schoop R, Raggam R, Koidl C, Kleinhappl B, Bauer R. Bioavailability and pharmacokinetic studies on Echinacea purpurea preparations and their interaction with the immune system.  Int J Clin Pharm Ther. 2006;  44 401-408
    PubMedGoogle Scholar
  • 22 Barnes J, Anderson L A, Gibbons S, Phillipson J D. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.  J Pharm Pharmacol. 2005;  57 929-954
    CrossrefPubMedGoogle Scholar
  • 23 Binns S E, Hudson J, Merali S, Arnason J T. Antiviral activity of characterized extracts from Echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-1).  Planta Med. 2002;  68 780-783
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Bodinet C, Beuscher N. Antiviral and immunological activity of glycoproteins from Echinacea purpurea Radix.  Planta Med. 1991;  57 (Suppl. 2) A33
    Article in Thieme ConnectPubMedGoogle Scholar

Dr. Paul Schnitzler

Department of Virology
Hygiene Institute

Im Neuenheimer Feld 324

69120 Heidelberg

Germany

Phone: + 49 62 21 56 50 16

Fax: + 49 62 21 56 50 03

Email: Paul_Schnitzler@med.uni-heidelberg.de

      >